Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
Holding DNTH?
Track your performance easily

Dianthus Therapeutics (DNTH) Ownership - Who Owns Dianthus Therapeutics?

302 Followers

Dianthus Therapeutics (DNTH) Ownership Overview

29.06%17.80%0.71%9.64%42.79%
29.06% Insiders
0.71% Other Institutional Investors
9.64% ETFs
42.79% Public Companies and
Individual Investors
The ownership structure of Dianthus Therapeutics (DNTH) stock is a mix of institutional, retail, and individual investors. Approximately 28.15% of the company’s stock is owned by Institutional Investors, 29.06% is owned by Insiders, and 42.79% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$6478618

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,762,837Institution9.41%80,288,043
2,717,554Insider9.25%78,972,119
2,700,691Insider9.20%78,482,080
2,333,000Institution7.94%67,796,980
1,682,584Insider5.70%48,895,891
1,436,745Insider4.89%41,751,810
1,407,021Institution4.79%40,888,030
1,240,228Institution4.22%36,041,026
1,050,253Institution3.58%30,520,352
983,245Institution3.35%28,573,100

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,407,021Institution4.79%40,888,030
1,050,253Institution3.58%30,520,352
558,654Institution1.90%16,234,485
500,662Institution1.70%14,549,238
341,018Institution1.16%9,909,983
285,549Institution0.97%8,298,054
254,881Institution0.87%7,406,842
222,242Institution0.76%6,458,353
153,693Institution0.52%4,466,319
115,690Institution0.39%3,361,951

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
789,087Institution2.69%21,605,202
653,292Institution2.22%18,984,666
345,529Institution1.18%10,331,317
272,079Institution0.93%7,449,523
214,279Institution0.73%6,226,948
109,479Institution0.37%2,997,535
85,424Institution0.29%2,554,178
54,653Institution0.19%1,588,216
39,861Institution0.14%1,191,844
27,937Institution0.10%811,849

FAQ

Who Owns Dianthus Therapeutics (DNTH)?
According to the latest TipRanks data, approximately 0.71% of the company's stock is held by institutional investors, 29.06% is held by insiders, and 42.79% is held by retail investors.
    What percentage of Dianthus Therapeutics (DNTH) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.71% of Dianthus Therapeutics (DNTH) stock is held by institutional investors.
      What percentage of Dianthus Therapeutics (DNTH) stock is held by retail investors?
      According to the latest TipRanks data, approximately 42.79% of Dianthus Therapeutics (DNTH) stock is held by retail investors.
        Who owns the most shares of Dianthus Therapeutics (DNTH)?
        Peter Harwin owns the most shares of Dianthus Therapeutics (DNTH).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis